/ /

Oncology

Vismodegib study confirms safety, efficacy for BCCThe largest-ever vismodegib study in advanced basal cell carcinoma, the STEVIE study, confirms pivotal study findings in a real-world setting, helping dermatologists to provide a complete palette of skin cancer treatments.
New target could predict melanomaNew information could eventually help identify a high-risk population before they get cancer — even prevent skin cancer’s onset.
First do no Mohs harmAn expert advises evaluating each patient’s surrounding circumstances when determining whether Mohs surgery is indicated.
How to weigh benefit of Moh'sMohs surgery experts advise when Mohs is and isn’t optimal skin cancer treatment.
Improving accuracy in NMSC diagnosisThe trend toward smaller biopsies may compromise the accuracy of dermatopathologists' diagnoses.
EWG releases 2016 sunscreen recommendationsEWG, which focuses on consumer and environmental health, claims that 72 percent of 750 available sunscreens the group evaluated offer inferior protection or contain ingredients that could harm skin. Some pediatric dermatologists weigh in.
Scientists gain new insight into UV-exposure geneticsXeroderma pigmentosum is a rare disease that leads to early skin cancer. New insights may lead to better prevention and survival for patients, as well as point to ways that UV-resistant gene functions could be used for skin cancer prevention and treatment.
Gene tests predicts melanoma stagingA gene expression profile test rivals sentinel node biopsy in predicting distant metastasis in stage 1 and stage 2 melanoma, according to results from a new multicenter performance study.
Light-listening device could transform skin disease detectionThe future of skin cancer and other disease detection could change with the development of a photonics device that listens to light.
GlobalMed Technologies acquires Omnilux MedicalGlobalMed has represented medical and aesthetic dermatology brands, including BMT, CoolTouch and Radiancy, since 1996. Omnilux noninvasively treats dermatologic conditions, including acne, fine lines and wrinkles and non-melanoma skin cancer.

Poll

View Results